241 related articles for article (PubMed ID: 35626118)
1. Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging.
Manneh Kopp R; Espinosa-Olarte P; Alonso-Gordoa T
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626118
[TBL] [Abstract][Full Text] [Related]
2. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
[TBL] [Abstract][Full Text] [Related]
3. [
Giovannini E; Giovacchini G; Borsò E; Lazzeri P; Riondato M; Leoncini R; Duce V; Ciarmiello A
Curr Radiopharm; 2019; 12(1):11-22. PubMed ID: 30539709
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms.
Iravani A; Parihar AS; Akhurst T; Hicks RJ
Cancer Imaging; 2022 Jun; 22(1):25. PubMed ID: 35659779
[TBL] [Abstract][Full Text] [Related]
5. The Correlation Between [
Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
[TBL] [Abstract][Full Text] [Related]
6. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
[TBL] [Abstract][Full Text] [Related]
8. The value of
Liu KY; Goldrich DY; Ninan SJ; Filimonov A; Lam H; Govindaraj S; Iloreta AM
Head Neck; 2021 Jun; 43(6):E30-E40. PubMed ID: 33786927
[TBL] [Abstract][Full Text] [Related]
9.
Carlsen EA; Johnbeck CB; Binderup T; Loft M; Pfeifer A; Mortensen J; Oturai P; Loft A; Berthelsen AK; Langer SW; Knigge U; Kjaer A
J Nucl Med; 2020 Oct; 61(10):1491-1497. PubMed ID: 32111685
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of
Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.
Danti G; Flammia F; Matteuzzi B; Cozzi D; Berti V; Grazzini G; Pradella S; Recchia L; Brunese L; Miele V
Radiol Med; 2021 Dec; 126(12):1497-1507. PubMed ID: 34427861
[TBL] [Abstract][Full Text] [Related]
12. Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms.
Takayanagi D; Cho H; Machida E; Kawamura A; Takashima A; Wada S; Tsunoda T; Kohno T; Shiraishi K
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267427
[TBL] [Abstract][Full Text] [Related]
13. Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
[TBL] [Abstract][Full Text] [Related]
14. Role of Combined
Kaewput C; Vinjamuri S
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204371
[TBL] [Abstract][Full Text] [Related]
15. Medical Treatment of Gastrointestinal Neuroendocrine Neoplasms.
Tsoli M; Alexandraki K; Xanthopoulos C; Kassi E; Kaltsas G
Horm Metab Res; 2020 Aug; 52(8):614-620. PubMed ID: 32108932
[TBL] [Abstract][Full Text] [Related]
16. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
Kidd M; Modlin I; Öberg K
Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044
[TBL] [Abstract][Full Text] [Related]
17. Influence of lanreotide on uptake of
Aalbersberg EA; de Wit-van der Veen BJ; Versleijen MWJ; Saveur LJ; Valk GD; Tesselaar MET; Stokkel MPM
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):696-703. PubMed ID: 30097670
[TBL] [Abstract][Full Text] [Related]
18. NEN - the role of somatostatin receptor scintigraphy in clinical setting.
Opalińska M; Hubalewska-Dydejczyk A; Sowa-Staszczak A; Stefańska A
Nucl Med Rev Cent East Eur; 2016; 19(2):118-25. PubMed ID: 27479789
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
